ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Regeneron Pharmaceuticals, Inc.
(NQ:
REGN
)
242.76
USD
+10.05 (+4.32%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
888,597
Open
233.64
Bid (Size)
242.72 (400)
Ask (Size)
242.76 (100)
Prev. Close
232.71
Today's Range
230.51 - 244.26
52wk Range
107.31 - 283.99
Shares Outstanding
95,908,088
Dividend Yield
N/A
Featured News
More News
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves.
Read More
category
REGN
,
Biotechnology
,
Opinion
, and 24 more.
from
MarketWatch
Friday’s movers: LinkedIn, Delcath Systems
May 03, 2013
Shares of Regeneron Pharmaceuticals led the S&P 500 in premarket trade on Friday while LinkedIn Corp. and Delcath Systems shares fell. Warren Buffett’s Berkshire Hathaway dominated investor attention.
Read More
category
LNKD
,
REGN
,
Internet Hardware
, and 14 more.
from
MarketWatch
Featured News
Read More
Minyanville's T3 Morning Market Call: Market Once Again Takes Aim at Highs After Swift Snapback
April 10, 2013
category
REGN
,
MSFT
,
NFLX
from
Minyanville Headlines
Minyanville's T3 Morning Market Call: Is Lousy Jobs Report Actually Good News for Market?
April 08, 2013
category
REGN
,
BA
,
NFLX
, and 2 more.
from
Minyanville Headlines
Regeneron Shares Jump as Sanofi Increases Stake
February 11, 2013
from
Minyanville Headlines
Novo Nordisk shares plunge on FDA rejection
February 11, 2013
category
Market News
,
REGN
,
Biotechnology
, and 12 more.
from
MarketWatch
Stock Downgrades: Boeing About to Crash
January 17, 2013
from
Minyanville Headlines
Kindred, Celgene get diverging Street ratings
January 08, 2013
category
Market News
,
REGN
,
CELG
, and 9 more.
from
MarketWatch
More News
Read More
5 Undervalued Stocks Flying Under The Radar!
Today 12:25 EDT
category
NASDAQ:MEIP
,
NASDAQ:REGN
,
NASDAQ:ICPT
, and 2 more.
from
Forbes Real Time
Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19
Today 10:39 EDT
category
ELN
,
Benzinga
,
REGN
, and 11 more.
from
Latest Articles from Benzinga.com
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
Today 7:11 EDT
from
StreetInsider.com News Articles
Critical Alerts For Cisco Systems, Regeneron Pharmaceuticals, Linn Energy, Myriad Genetics, and InvenSense Released By InvestorsObserver
June 17, 2013
from
PR Newswire
A Growth Investor Who Smartly Balances Blue Chips And Biotech
June 13, 2013
category
NASDAQ:GOOG
,
NYSE:WMT
,
NASDAQ:CRM
, and 2 more.
from
Forbes Real Time
Bio-Wire Equity Surveillance – Closing Bell 6/12/2013
June 12, 2013
category
REGN
,
QCOR
,
TEVA
, and 4 more.
from
Bio-Wire.Com
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Notable ETF Outflow Detected - IBB, REGN, AMGN, CELG
June 12, 2013
category
ETFs
from
ETF Channel
Market Wrap for Thursday, June 6: Stocks Reverse Mid-Day; Rally to Close at Session Highs
June 06, 2013
category
Earnings
,
Benzinga
,
REGN
, and 28 more.
from
Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 6/6/2013
June 06, 2013
category
REGN
,
ENDP
,
MNTA
, and 3 more.
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
5
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
See All Articles
»